Share on StockTwits

Mindray Medical International Ltd (NYSE:MR) will be announcing its Q214 earnings results on Monday, August 11th. Analysts expect the company to announce earnings of $0.54 per share and revenue of $348.30 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Shares of Mindray Medical International Ltd (NYSE:MR) opened at 29.81 on Friday. Mindray Medical International Ltd has a 1-year low of $29.28 and a 1-year high of $43.81. The stock’s 50-day moving average is $30.79 and its 200-day moving average is $32.44. The company has a market cap of $3.483 billion and a P/E ratio of 17.94.

On the ratings front, analysts at Jefferies Group cut their price target on shares of Mindray Medical International Ltd from $36.00 to $32.00 in a research note on Thursday, May 22nd. They now have a “hold” rating on the stock. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Mindray Medical International Ltd has a consensus rating of “Hold” and an average target price of $35.07.

Mindray Medical International Limited (NYSE:MR), is a developer, manufacturer and marketer of medical devices worldwide.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.